(FM) Inmunología
Departamento académico
University of Bari Aldo Moro
Bari, ItaliaPublicaciones en colaboración con investigadores/as de University of Bari Aldo Moro (2)
2024
2023
-
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial
Journal of Clinical Oncology, Vol. 41, Núm. 2, pp. 212-221